| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.02 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |